Prenetics Global Soars 13.05% on Strategic Partnerships, Certifications

Prenetics Global's stock surged by 13.05% in pre-market trading on May 23, 2025, driven by a series of strategic initiatives and partnerships that have bolstered investor confidence in the company's growth prospects.

Prenetics Global has been actively expanding its scientific advisory board, which includes prominent figures in the health and wellness industry. This move is part of the company's broader strategy to enhance its product offerings and reinforce its commitment to setting new standards in the supplements market. Additionally, Prenetics' IM8 Health has achieved NSF Certified for Sport certification for its Daily Ultimate Essentials, further validating the quality and efficacy of its products.

In a significant development, Prenetics announced a genomics-based partnership with Humanity Protocol, launching a crypto strategic reserve. This partnership not only diversifies Prenetics' revenue streams but also positions the company at the forefront of the emerging intersection between genomics and blockchain technology. Furthermore, Prenetics' collaboration with the Mayo Clinic to develop a new line of premium supplements underscores its dedication to innovation and excellence in the health sciences sector.

Prenetics' participation in key industry conferences, such as the 37th Annual ROTH Conference, has provided the company with valuable opportunities to engage with investors and industry experts. These engagements have helped to raise Prenetics' profile and generate interest in its long-term growth potential. The company's strategic initiatives and partnerships have collectively contributed to a positive market sentiment, driving the recent surge in its stock price.